Global 3D Printed Drugs Market Size, Trends & Growth Opportunity, By Technology, By End-Use, By Application, By Region and Forecast Till 2027.

Global 3D Printed Drugs Market Size, Trends & Growth Opportunity, By Technology, By End-Use, By Application, By Region and forecast till 2027.

Global 3D Printed Drugs Market

Global 3D Printed Drugs Market was valued at $291.82 million in 2021 and is predicted to reach up to $458.52 million by 2027 at a CAGR of 7.8% from 2022-2027.

Custom-made prosthetics, implants, and other medical items are being produced using 3D printing technology more frequently in the medical sector. Even 3D bio-printed organs are being created using 3D printing technology. Pharmacy technicians and medical engineers can now edit a drug's design directly in its CAD file thanks to technology used in the pharmaceutical sector. Additionally, it enables the healthcare provider to print medications as needed rather than in bulk.

Prescriptions for safe and effective custom pharmaceuticals are made utilising the 3D printing method and are known as 3D printed drugs. These drugs don't require swallowing huge doses whole since they have a unitary porous architecture that disperses quickly in the mouth. It makes it simple for manufacturers to change a variety of medications' size, shape, appearance, form, and rate of distribution. Patients who frequently struggle with swallowing, kids, seniors, those living with stroke, Alzheimer's disease, head and neck cancers, and other neurological problems can all benefit from this type of drug.

Market Drivers

The primary driver of the growth of the global 3D printed medicines market is the surge in demand for instantly soluble drugs that can disperse readily in the mouth. Additionally, the rise in the prevalence of dysphagia, the use of 3D printing in the medical and healthcare sectors, the adoption of personalised medicines, and the creation of combination medicines all contribute to the market's expansion. The industry is flourishing because to the increased demand for personalised medications and the quickly expanding R&D activities that support 3D printing.

Pharmaceuticals created via 3D printing are gaining popularity since they are simple to consume and practically instantly dissolve. Personalized treatments can better support patients than batch-produced medications since they can be tailored to each patient's unique needs. As a result, it is anticipated that the market for these medications would grow during the forecast period.

Market Restraints

The market's expansion is constrained by negative drug-related side effects, the use of 3D printing to create illicit pharmaceuticals, and a lack of government restrictions for 3D printed goods.

Impact of COVID-19

The use of 3D printing has increased as a result of the COVID-19 outbreak. To help with the creation of medicines and other necessary products, the operational actors in the advanced manufacturing industry have introduced a number of 3D printers. Additionally, the COVID-19 pandemic's drug shortage has raised pharmaceutical companies' attention to the idea of using 3D printing technology to supply medications quickly.

Market Segmentation

The Global 3D Printed Drugs Market is segmented into Technology, End-Use, Application. By Technology such as Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose

Technology. By End-Use such as Hospitals & clinics, Research Laboratories, Others. By Application such as Orthopedic, Neurology, Dental, Hearing & Audibility Aid, Others.

Regional Analysis

The Global 3D Printed Drugs Market is segmented into five regions North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. With a share of 37.23% in the regional market in 2021, North America held the majority of the market. The high prevalence of chronic diseases, the superior domestic healthcare infrastructure, the significant investment in R&D, and the rising adoption of technology advancements in the North American region are all factors that contribute to this significant proportion. Due to considerable advancements made by China and Japan in the technological application of 3D printed medication techniques, the Asia Pacific is predicted to have the quickest growth rate. Additionally, the expansion of clinical development frameworks, R&D, and healthcare infrastructure in rising nations like Australia and India has positioned the Asia Pacific market to see profitable prospects and growth over the course of the projection period.

Kay Players

This report includes a list of numerous Key Players, namely Aprecia, Extend Biosciences, Bioduro, Affinity Therapeutics, Osmotica Pharmaceuticals, Aprecia Pharmaceuticals LLC, GlaxoSmithKline Plc, FabRx Ltd, Hewlett Packard Caribe, Merck.

Market Taxonomy

By Technology

• Inkjet Printing
• Fused Deposition Modeling
• Stereolithography
• ZipDose Technology.

• Hospitals & clinics
• Research Laboratories
• Others

• Orthopedic
• Neurology
• Dental
• Hearing & Audibility Aid
• Others

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa